# Synchron

the Stentrode is implanted within the motor cortex via the jugular vein in an endovascular procedure with no craniotomy; Synchron reported positive results from the US COMMAND early-feasibility study and is positioning a 2026 pivotal trial targeting the first FDA commercial approval in motor BCI.

Source: https://en.bioecon.ru/companies/synchron/
Updated: 2026-06-28

- Country: United States
- Ticker: private

## Technologies

- [Neurointerfaces & brain–computer interfaces](https://en.bioecon.ru/technology/neurointerfaces-bci/)